- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about NVAX
Recent news which mentions NVAX
From Benzinga
1 Growth Stock With 741% Upside, According to Wall Street
March 30, 2023
Tickers
NVAX
From Motley Fool
From InvestorPlace
3 Stocks That Won’t Survive a Major Market Crash
March 23, 2023
From InvestorPlace
A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats
March 20, 2023
From Benzinga
From Motley Fool
3 Vaccine Stocks to Watch for Their Post-Pandemic Moves
March 14, 2023
From InvestorPlace
This Growth Stock Is Down 90%. Is It Time to Sell or Buy?
March 12, 2023
Tickers
NVAX
From Motley Fool
Novavax Stock: Bear vs. Bull
March 10, 2023
From Motley Fool
Novavax Just Dropped a Bombshell on Investors: Even Management Is Questioning Its Future
March 08, 2023
Tickers
NVAX
From Motley Fool
FDA's Regulatory Delay is The Reason For Novavax, Lucira Health's Failure: WSJ Report
March 07, 2023
From Benzinga
US Stocks Could Consolidate As S&P 500, Nasdaq Futures Tick Up Ahead Of Fed Chair Powell's Congressional Testimony
March 06, 2023
From Benzinga
Esperion Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
March 06, 2023
From Benzinga
Benzinga Bulls And Bears: Tesla, Microsoft, Apple, Novavax And Why Dogecoin May Be Poised For 50% Surge
March 04, 2023
From Benzinga
Should You Give Up on Novavax?
March 03, 2023
From Motley Fool
Nasdaq, S&P Futures Slide As Bond Yields Stay Above 4%: Economic Signals Ominous But Don't Panic Yet, Says Analyst
March 02, 2023
From Benzinga
From Benzinga
5 Investors Still Betting Big on Novavax (NVAX) Stock
March 01, 2023
From InvestorPlace
Jim Cramer Says He's Known Novavax Is 'Worthless' For 'Very Long Time,' Trashes Company For Being Too 'Promotional'
March 01, 2023
From Benzinga
Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 01, 2023
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 01, 2023
From Benzinga
NVAX Stock Alert: Is Novavax Going Bankrupt?
March 01, 2023
From InvestorPlace
From Benzinga
Why Is Sarepta Therapeutics (SRPT) Stock Up 21% Today?
March 01, 2023
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.